1. Home
  2. QUBT vs LEXX Comparison

QUBT vs LEXX Comparison

Compare QUBT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$6.66

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.73

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
LEXX
Founded
2001
2004
Country
United States
Canada
Employees
N/A
7
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
16.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
QUBT
LEXX
Price
$6.66
$0.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$17.00
$1.50
AVG Volume (30 Days)
9.2M
141.9K
Earning Date
03-02-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
N/A
EPS
N/A
N/A
Revenue
$682,000.00
N/A
Revenue This Year
$3,210.56
N/A
Revenue Next Year
$51.26
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
82.84
N/A
52 Week Low
$5.76
$0.46
52 Week High
$25.84
$1.75

Technical Indicators

Market Signals
Indicator
QUBT
LEXX
Relative Strength Index (RSI) 34.37 53.26
Support Level N/A $0.62
Resistance Level $9.15 $0.87
Average True Range (ATR) 0.40 0.07
MACD 0.03 0.00
Stochastic Oscillator 2.23 52.48

Price Performance

Historical Comparison
QUBT
LEXX

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: